Cme Group annual total liabilities
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Total Liabilities Growth & History (CME)
Cme Group's total liabilities was $169.70B for fiscal 2025.
View full Cme Group company overviewCme Group annual total liabilities history
| Fiscal year | Period ended | Total liabilities | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $169.70B | $58.74B | +52.93% |
| 2024 | 2024-12-31 | $110.96B | $7.99B | +7.76% |
| 2023 | 2023-12-31 | $102.97B | −$44.33B | −30.09% |
| 2022 | 2022-12-31 | $147.30B | −$22.08B | −13.04% |
| 2021 | 2021-12-31 | $169.38B | $71.07B | +72.30% |
| 2020 | 2020-12-31 | $98.31B | $49.25B | +100.40% |
| 2019 | 2019-12-31 | $49.06B | −$2.45B | −4.76% |
| 2018 | 2018-12-31 | $51.51B | −$1.87B | −3.50% |
| 2017 | 2017-12-31 | $53.38B | $4.35B | +8.87% |
| 2016 | 2016-12-31 | $49.03B | $2.22B | +4.75% |
| 2015 | 2015-12-31 | $46.81B | −$4.51B | −8.79% |
| 2014 | 2014-12-31 | $51.32B | $18.20B | +54.96% |
| 2013 | 2013-12-31 | $33.12B | $15.76B | +90.80% |
| 2012 | 2012-12-31 | $17.36B | −$1.78B | −9.30% |
| 2011 | 2011-12-31 | $19.14B | $4.22B | +28.28% |
| 2010 | 2010-12-31 | $14.92B | −$1.43B | −8.76% |
| 2009 | 2009-12-31 | $16.35B | −$13.12B | −44.52% |
| 2008 | 2008-12-31 | $29.47B | — | — |
Cme Group quarterly total liabilities
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total liabilities | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $168.16B | $15.99B | +10.51% |
| Q1 2026 | 2026-03-31 | $175.38B | $44.57B | +34.08% |
| Q4 2025 | 2025-12-31 | $169.70B | $58.74B | +52.93% |
| Q3 2025 | 2025-09-30 | $158.95B | $49.38B | +45.06% |
| Q2 2025 | 2025-06-30 | $152.17B | $56.42B | +58.93% |
| Q1 2025 | 2025-03-31 | $130.80B | $25.90B | +24.69% |
| Q4 2024 | 2024-12-31 | $110.96B | $7.99B | +7.76% |
| Q3 2024 | 2024-09-30 | $109.58B | $12.13B | +12.45% |
| Q2 2024 | 2024-06-30 | $95.74B | −$27.74B | −22.46% |
| Q1 2024 | 2024-03-31 | $104.90B | −$33.76B | −24.34% |
| Q4 2023 | 2023-12-31 | $102.97B | −$44.33B | −30.09% |
| Q3 2023 | 2023-09-30 | $97.45B | −$52.73B | −35.11% |
| Q2 2023 | 2023-06-30 | $123.48B | −$25.19B | −16.94% |
| Q1 2023 | 2023-03-31 | $138.65B | −$39.53B | −22.18% |
| Q4 2022 | 2022-12-31 | $147.30B | −$22.08B | −13.04% |
| Q3 2022 | 2022-09-30 | $150.18B | −$9.31B | −5.84% |
| Q2 2022 | 2022-06-30 | $148.67B | −$3.24B | −2.13% |
| Q1 2022 | 2022-03-31 | $178.18B | $44.08B | +32.88% |
| Q4 2021 | 2021-12-31 | $169.38B | $71.07B | +72.30% |
| Q3 2021 | 2021-09-30 | $159.49B | $60.74B | +61.51% |
| Q2 2021 | 2021-06-30 | $151.91B | $61.54B | +68.09% |
| Q1 2021 | 2021-03-31 | $134.10B | $22.76B | +20.45% |
| Q4 2020 | 2020-12-31 | $98.31B | $49.25B | +100.40% |
| Q3 2020 | 2020-09-30 | $98.75B | $46.14B | +87.72% |
| Q2 2020 | 2020-06-30 | $90.38B | $46.51B | +106.03% |
| Q1 2020 | 2020-03-31 | $111.33B | $65.91B | +145.08% |
| Q4 2019 | 2019-12-31 | $49.06B | −$2.45B | −4.76% |
| Q3 2019 | 2019-09-30 | $52.60B | $5.54B | +11.76% |
| Q2 2019 | 2019-06-30 | $43.86B | −$2.21B | −4.80% |
| Q1 2019 | 2019-03-31 | $45.43B | −$1.72B | −3.65% |
| Q4 2018 | 2018-12-31 | $51.51B | −$1.87B | −3.50% |
| Q3 2018 | 2018-09-30 | $47.07B | −$10.39B | −18.08% |
| Q2 2018 | 2018-06-30 | $46.08B | −$11.69B | −20.24% |
| Q1 2018 | 2018-03-31 | $47.15B | −$7.78B | −14.16% |
| Q4 2017 | 2017-12-31 | $53.38B | $4.35B | +8.87% |
| Q3 2017 | 2017-09-30 | $57.46B | $15.47B | +36.85% |
| Q2 2017 | 2017-06-30 | $57.77B | $11.22B | +24.09% |
| Q1 2017 | 2017-03-31 | $54.92B | $7.00B | +14.60% |
| Q4 2016 | 2016-12-31 | $49.03B | $2.22B | +4.75% |
| Q3 2016 | 2016-09-30 | $41.99B | −$17.59B | −29.52% |
| Q2 2016 | 2016-06-30 | $46.55B | −$5.85B | −11.17% |
| Q1 2016 | 2016-03-31 | $47.93B | −$8.11B | −14.47% |
| Q4 2015 | 2015-12-31 | $46.81B | −$4.51B | −8.79% |
| Q3 2015 | 2015-09-30 | $59.57B | $17.14B | +40.39% |
| Q2 2015 | 2015-06-30 | $52.40B | $22.26B | +73.84% |
| Q1 2015 | 2015-03-31 | $56.03B | $24.18B | +75.89% |
| Q4 2014 | 2014-12-31 | $51.32B | $18.20B | +54.96% |
| Q3 2014 | 2014-09-30 | $42.43B | $15.43B | +57.15% |
| Q2 2014 | 2014-06-30 | $30.15B | $5.12B | +20.45% |
| Q1 2014 | 2014-03-31 | $31.86B | $11.07B | +53.28% |
| Q4 2013 | 2013-12-31 | $33.12B | $15.76B | +90.80% |
| Q3 2013 | 2013-09-30 | $27.00B | $8.93B | +49.43% |
| Q2 2013 | 2013-06-30 | $25.03B | $8.78B | +54.04% |
| Q1 2013 | 2013-03-31 | $20.78B | $3.11B | +17.62% |
| Q4 2012 | 2012-12-31 | $17.36B | −$1.78B | −9.30% |
| Q3 2012 | 2012-09-30 | $18.07B | $116.0M | +0.65% |
| Q2 2012 | 2012-06-30 | $16.25B | $1.63B | +11.16% |
| Q1 2012 | 2012-03-31 | $17.67B | $3.82B | +27.55% |
| Q4 2011 | 2011-12-31 | $19.14B | $4.22B | +28.28% |
| Q3 2011 | 2011-09-30 | $17.95B | $4.24B | +30.88% |
| Q2 2011 | 2011-06-30 | $14.62B | −$191.4M | −1.29% |
| Q1 2011 | 2011-03-31 | $13.85B | −$2.09B | −13.12% |
| Q4 2010 | 2010-12-31 | $14.92B | −$1.43B | −8.76% |
| Q3 2010 | 2010-09-30 | $13.72B | −$3.67B | −21.11% |
| Q2 2010 | 2010-06-30 | $14.81B | −$4.74B | −24.26% |
| Q1 2010 | 2010-03-31 | $15.95B | — | — |
| Q4 2009 | 2009-12-31 | $16.35B | −$13.12B | −44.52% |
| Q3 2009 | 2009-09-30 | $17.39B | — | — |
| Q2 2009 | 2009-06-30 | $19.55B | — | — |
| Q4 2008 | 2008-12-31 | $29.47B | — | — |
Cme Group total liabilities trends
Over the last five fiscal years, Cme Group's total liabilities increased from $98.31B to $169.70B, a change of $71.39B. The latest reported quarter, Q2 2026, shows $168.16B.
About the metric
What total liabilities mean
Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.
Calculation and source
SEC-reported and calculated total liabilities
TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...